16 Gy radiation-first treatment strategy: baseline characteristics (N=13)
| Gender | |
| Male | 5 (38%) |
| Female | 8 (62%) |
| Age | |
| Mean | 72.7 |
| Age category | |
| 50–64 years | 1(8%) |
| 65–74 years | 8 (62%) |
| 75–84 years | 3 (23%) |
| >85 years | 1(8%) |
| Race | |
| Hispanic/Latino | 13 (100%) |
| Letters of visual acuity | |
| <55 letters | 8 (62%) |
| ≥55 letters | 5 (38%) |
| ETDRS BCVA at enrolment | |
| Mean | 45.5 |
| Previous therapy for AMD | |
| Anti-vascular endothelial growth factor monotherapy | 1 (8%) |
| Photodynamic therapy | – |
AMD, age-related macular degeneration; BCVA, best corrected visual acuity; ETDRS, Early Treatment of Diabetic Retinopathy Study.